United States of America to Confront Autism Epidemic Under Kennedy Leadership: A Turning Point for Environmental Health Science, Public Health, and Medicine

Next Steps for Policy and Public Health Research

In a landmark press conference on April 16, 2025, U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. delivered a sobering diagnosis—not of a child, but of an entire nation. Flanked by researchers, parents, and reporters, Kennedy declared that the United States is facing a public health crisis of staggering proportions: the autism epidemic. The numbers he cited were not projections or hypothetical models. They were hard, government-issued statistics from the Centers for Disease Control and Prevention (CDC): as of 2022, 1 in 31 American 8-year-olds—more than 3.2%—carry a diagnosis of autism spectrum disorder (ASD), a sharp rise from 1 in 36 just two years prior​​. Among boys, the rate is even more harrowing: 1 in 20 nationally, and in California, where tracking systems are most sophisticated, a staggering 1 in 12.5​​.

“This is not just a public health issue,” Kennedy stated. “It is a national emergency.”

These numbers are not outliers or isolated spikes. They reflect a long-standing, uninterrupted upward trajectory that began in the early 1990s and has continued through every revision of diagnostic criteria, every public awareness campaign, and every wave of technological advancement in health surveillance. In 2000, the CDC estimated that 1 in 150 children had autism. In the 1970s, the rate was 1 in 10,000​. This means the current figure represents more than a 300-fold increase over historical estimates—a climb far too steep to attribute to mere improvements in detection. When challenged by a reporter if he denied that efforts to bring healthcare to “underserved populations” were contributing to the rise in autism cases, Kennedy estimated at least 85% of the increase is real.

And yet, that is precisely the line many public health officials and media outlets continue to promote. In a coordinated media response following the CDC’s 2025 report, major outlets such as The Washington Post, NPR, and The Hill characterized the rise as “slight” and credited the increase to “better screening” or expanded diagnostic definitions​. Kennedy forcefully rejected these explanations, calling them “industry canards” designed to deflect attention from a growing body of evidence pointing toward environmental causation.

He’s not alone. Joining him at the press conference was Dr. Walter Zahorodny, lead autism prevalence researcher at Rutgers University and principal investigator for New Jersey’s Autism and Developmental Disabilities Monitoring (ADDM) site. Zahorodny emphasized that the rise in autism is not a diagnostic illusion: “There is better awareness of autism,” he said, “but better awareness cannot be driving a disability like autism to increase by 300% in 20 years”​.

This moment marks a historic inflection point—what public philosophers of science might call an epistemic break. For the first time in modern history, a sitting HHS Secretary is rejecting the dogmatic notion that autism’s explosive rise is an artifact of increased awareness. Instead, Kennedy is calling it what the data clearly show it to be: a genuine epidemic of neurological and immunological injury in children, one that demands immediate, rigorous investigation.

To that end, Kennedy announced that the Department of Health and Human Services, in coordination with the CDC and independent global researchers, has launched a sweeping, agnostic inquiry into the environmental causes of autism. This effort, involving hundreds of scientists, will not be limited to politically safe topics or agency-approved hypotheses. It will include examination of pesticides, food additives, water and air pollution, pharmaceuticals, and—yes—vaccines and their ingredients. “We are going to look at every plausible cause,” Kennedy said, “and we will follow the data wherever it leads.” The initiative promises preliminary results by September 2025​.

This declaration is more than symbolic. It represents the potential end of a decades-long pattern in which environmental hypotheses—particularly those implicating iatrogenic exposures such as vaccine adjuvants or medical interventions—have been marginalized, censored, or defunded. Kennedy’s announcement reflects a long-overdue course correction, not only for autism research but for the credibility of public health itself.

At stake is not merely scientific clarity, but a generation of children. The urgency could not be greater. As Kennedy warned, “We are losing our children. And we are doing it to ourselves.”

What follows in this report is a detailed synthesis of Kennedy’s policy pivot and the scientific literature that supports it. This report will dismantle the denialist narratives that have dominated public discourse, replacing them with a rigorous, testable, and biologically coherent framework. Autism is not a mystery. We have not failed to understand it. We have only failed to look where the truth resides.

And now, finally, that is beginning to change.

Autism Prevalence: A Real, Accelerating Epidemic

Despite persistent efforts to reframe autism as a benign neurodivergence or a diagnostic abstraction, the data tell a radically different story—one of exponential growth, expanding disability burden, and increasing severity. The numbers are not merely alarming—they are devastating.

According to the CDC’s 2025 Autism and Developmental Disabilities Monitoring (ADDM) Network report, the national prevalence of autism among 8-year-olds rose from 1 in 36 in 2020 to 1 in 31 in 2022, representing a 17% increase in just two years​​. The gender disparity is stark: among boys, the rate is 1 in 20, and in California—widely regarded as having the most rigorous autism surveillance systems—the number is 1 in 12.5​. These are not isolated spikes or outlier data points; they are the latest entries in a persistent trendline that has been climbing, unbroken, for decades.

What makes these findings even more consequential is the pattern among younger cohorts. In five of the CDC’s 16 study sites, the autism rate among 4-year-olds already exceeds that of 8-year-olds, strongly suggesting that future reports will show even higher national prevalence as these children age into formal diagnosis​. This undermines the assumption that we are merely detecting autism earlier. Rather, it signals that the baseline incidence continues to rise.

The massive scientific literature that existed ten years ago described this trajectory as not merely an increase but a pathological acceleration, one that can no longer be attributed to demographic shifts, diagnostic reclassification, or administrative factors. In my book, The Environmental and Genetic Causes of Autism, I reviewed a huge body of peer-reviewed evidence that systematically dismantles the artifact theory. For example, Nevison (2014) demonstrated that even after adjusting for changes in diagnostic criteria and increased awareness, the dramatic rise in autism diagnoses remains largely unexplained—unless environmental exposures are included in the model​.

Moreover, the nature of autism being diagnosed has changed in ways that defy the mainstream narrative. If the increase in prevalence were due primarily to better detection of high-functioning or mild cases, one would expect a concurrent increase in the proportion of children with higher IQs. But the opposite is true. The CDC report shows that nearly two-thirds of children diagnosed in 2022 had IQs below 85, meaning they are cognitively impaired or borderline​​. This figure has grown over time, not shrunk. These children are not “quirky geniuses” simply being noticed more—they are deeply disabled, often non-verbal, and require lifelong support.

This disproves what Kennedy termed the “epidemic denialism” narrative, repeated ad nauseam by academics and media outlets with deep entanglements in institutions historically resistant to environmental causation. The Washington Post, for example, labeled the 17% increase as “slight”​. But as Rutgers' Dr. Walter Zahorodny, one of the principal investigators in the CDC’s own surveillance network, countered, "Better awareness cannot be driving a disability like autism to increase by 300% in 20 years."

Existing science goes further, pointing to population-level implausibilities inherent in the artifact argument. If autism rates truly had remained constant over time, as some genetic determinists claim, we would expect to see comparable rates in adults over 35, including millions of severely affected individuals who would require intensive care, group housing, or institutional support. They are simply not there. Kennedy poses the blunt question: “Where are the older adults with profound autism?” The answer is self-evident: they never existed in such numbers, because something changed in the environment in recent decades that did not exist in previous generations​.

Kennedy, Zahorodny, and rational scientists converge on the same conclusion: the data are real, the increase is real, and the only scientifically responsible position is to treat the autism surge as a genuine epidemic. The public health implications are catastrophic. As Kennedy noted during the press conference, the rising rates of severe autism are not only devastating families—they are eroding the nation’s future:

“These are children who, many of them, were fully functional and regressed. They will never write a poem, never go out on a date, never live independently. We are doing this to our children, and we have to stop.”

Critics may bristle at the bluntness of this statement, but it reflects a deeper truth: ignoring the magnitude of the crisis in the name of social comfort or political expediency is itself a form of abandonment. It is not Kennedy who is stigmatizing the disabled—it is the mainstream public health establishment that has failed them, by refusing to investigate why the disability is becoming so much more common.

That said, Kennedy might have done well to point out that The Spellers program is revealing an army of previously non-communicative poets, philosophers, scientists and politicians in young adults who suffered the environmental exposures that revealed their genetic susceptibility.

In the next section, we will examine the inadequacy of genetic determinism to explain the autism epidemic and explore why the scientific consensus must shift toward gene-environment interaction as the primary lens of investigation.

Debunking Genetic Fatalism: Why the DNA-Only Model Fails

For years, the dominant narrative within the academic autism research community has framed autism as a largely genetic condition—heritable, polygenic, and largely inevitable. This view has been reinforced by high-profile studies, press releases from research universities, and public messaging by organizations such as the National Institutes of Health (NIH). But as the prevalence of autism continues to climb far beyond what genetic drift or selection pressure could plausibly account for, the credibility of this paradigm has quietly eroded.

At his April 16 press conference, Secretary Robert F. Kennedy Jr. called this genetic focus a “dead end”—not as a rhetorical flourish, but as a reflection of decades of failed research investment. He noted that NIH has historically spent 10 to 20 times more funding on genetic studies than on environmental causation, despite genetic studies yielding no actionable prevention strategies and no therapies for reversal or mitigation​. Kennedy’s administration plans to rebalance this ratio, investing heavily in exploring environmental, toxicological, and iatrogenic risk factors that may explain the steep rise in autism rates over recent decades.

In my book, The Environmental and Genetic Causes of Autism, I showed that the science already provides an extensive, evidence-based dissection of the genetic determinist narrative—and it is damning. While acknowledging that certain genetic variants may contribute to autism risk, the studies shows that:

• No single gene accounts for more than 1% of autism cases, even in the most generous interpretations of genome-wide association studies (GWAS).

• Most genetic “risk loci” lack replication across populations and suffer from methodological flaws, including failure to control for environmental exposure or epigenetic activation.

• Studies citing high heritability (e.g., 64–91%) conflate genetic inheritance with familial risk, which includes shared environment and lifestyle factors, including prenatal exposures​.

This distinction is crucial. Concordance in monozygotic twins may reflect shared gestational environment and immune exposures rather than inherited mutations. He cites studies such as Sandin et al. (2011), which estimated the heritability of autism at around 50%, and Hallmayer et al. (2011), which found that environmental factors accounted for at least half of autism liability, including gene-environment interactions​.

To illustrate the inadequacy of the genetics-only model, consider the “missing heritability” problem. In theory, if autism were primarily genetic, then genome-wide scans would reveal consistent, high-effect mutations. Instead, the findings have been underwhelming:

• The largest GWAS to date has implicated hundreds of genes, but each explains only a tiny fraction of risk.

• The effect sizes are so small that they fail to distinguish autistic individuals from non-autistic peers in clinical settings.

• Many implicated genes are involved in basic neurodevelopmental processes, which makes them non-specific: mutations in these same pathways are implicated in epilepsy, ADHD, intellectual disability, and even schizophrenia.

Moreover, the research exposes a conceptual flaw that haunts much of this research: the idea that increased autism prevalence must be genetic if it clusters in families. In reality, this ignores the growing literature on shared environmental toxicants, maternal immune activation, and iatrogenic exposures as intergenerational transmitters of risk. In fact, he recommends a more accurate term than “genetic risk”: familial risk, which captures both heritable and non-heritable shared determinants​.

Equally problematic is the overreliance on animal models that simulate autism by knocking out genes unrelated to any real-world environmental context. This leads to a circular trap: identifying a gene mutation that causes autistic behavior in a mouse, and then searching for that mutation in humans—without asking whether the same phenotype can be induced by toxicant exposure in the absence of the mutation, a phenomenon known as “phenomimicry”.

One striking example is the interaction of terbutaline, a common obstetric drug used to delay labor, with adrenergic receptors. Connors et al. (2005) found that overstimulation of these receptors mimics the effects of a genetic polymorphism known to be associated with autism—resulting in the same neuroanatomical changes. In this case, environment mimics mutation. This single insight demolishes the naive view that genes alone explain autism incidence​.

In sum, the gene-only model is not merely scientifically flawed—it is obstructive. It has derailed the autism research agenda for decades, funneling billions of dollars into studies that ignore the most obvious factor behind epidemic growth: the environment in which children develop. Kennedy’s pledge to redirect research funding represents not only a course correction, but a demand that public science finally ask the hard questions it has long avoided.

In the next section, we will explore these gene-environment interactions in detail, examining how specific genetic susceptibilities may amplify the effects of environmental exposures—and why this framework offers the most promising path toward prevention, mitigation, and, ultimately, solutions.

Gene × Environment Interactions (G × E): The Smoking Gun?

While genetic fatalism has dominated autism research funding and institutional narratives, the science has long pointed to a more sophisticated and biologically plausible model: gene-environment interaction (G × E). This framework does not reject genetic contributions, but rather recognizes that susceptibility genes require environmental triggers to manifest pathologically. It is, in fact, the only model that can explain both the familial clustering and the explosive rise in incidence within a single generation.

In the current stagnant science on autism, G × E as the missing link that reconciles genetic architecture with real-world epidemiology. Genetic studies have left out environmental factors, and vice versa, meaning the interaction term G × E has never been tested. The evidence is not speculative—it is empirical, mechanistic, and increasingly replicable. G × E offers a testable, actionable model, which is exactly why, he argues, it has been neglected by those invested in research that yields neither accountability nor prevention.

Simple G × E: Specific Genes, Specific Toxicants

The literature includes numerous studies identifying well-defined interactions between specific genes and environmental exposures. Some of the most compelling examples include:

• PON1 × Organophosphates:
  PON1 encodes an enzyme that detoxifies organophosphate pesticides. Children with low-functioning PON1 variants are less able to eliminate these neurotoxicants, leading to increased risk of autism following prenatal or early-life exposure​.

• ADRB2 × Maternal Stress:
  A variant of the adrenergic beta-2 receptor gene (ADRB2) interacts with maternal stress to dysregulate neurodevelopment. These stress-induced epigenetic changes can result in behavioral anomalies consistent with ASD phenotypes​.

• MET × Traffic-Related Air Pollution:
  The MET gene, which is involved in neural cell migration and immune function, shows strong interaction with fine particulate matter exposure. Children with risk alleles have dramatically increased vulnerability to pollution-induced cortical disruption​.

These examples underscore that some genetic information can tell us which environmental exposures are most dangerous within a family or individual—information that could be used today to tailor preventative strategies.

Complex G × E: The Epigenetic Cascade

Beyond these simple models, more complex interactions involve immune system activation, maternal infections, and cumulative toxicant burdens, which in turn modulate the expression of neurodevelopmental genes. For instance:

• Mazina et al. (2015) found that children with certain copy number variations (CNVs) developed core autistic features only when their mothers experienced prenatal infections—a synergy that did not affect cognition or adaptive functioning, but directly impaired social and behavioral development​.

• Maternal immune activation (MIA) has been shown to elevate IL-17a cytokines, leading to cortical disorganization in fetal brains—a hallmark of autism. These effects do not require genetic mutation, but are amplified in those with susceptibility loci in glutamate receptor or serotonin pathway genes​.

• Viral infections in infancy—such as mumps, chickenpox, and ear infections—have also been linked to higher ASD rates. Deykin and MacMahon (1979) were among the first to show that children who experienced multiple common viral illnesses in the first 18 months of life had significantly higher autism risk—a relationship later confirmed in larger cohort studies​.

Taken together, these studies reveal an inescapable truth: genes do not act in isolation. They form a sensitive blueprint, vulnerable to modification, disruption, or acceleration by environmental inputs. This, in turn, produces not only variable phenotypes, but variable windows of susceptibility, depending on timing, dosage, and cumulative burden.

Phenomimicry: When the Environment Masquerades as Mutation

One of the most important but less-known factors is the concept of phenomimicry—a phenomenon whereby environmental exposures mimic the effects of genetic mutations. This is not just metaphorical. He cites the case of terbutaline, an obstetric drug used to delay labor, which overstimulates adrenergic receptors in a way that produces the same neuroanatomical changes as a known genetic polymorphism in those same receptors​.

This insight reveals the peril of relying exclusively on genetic explanations: if the same phenotype can result from either mutation or toxicant, then focusing only on DNA guarantees that environmental causation will be overlooked, misattributed, or dismissed. It also illustrates why genetic variation may be necessary but not sufficient to cause autism.

A Systems Model of Autism Risk

Autism risk should ideally be studied by the formal framework:

Risk = f(G+E+(GxE))

Where:

• G = true genetic risk (of susceptibility of any kind)

• E = true environmental risk

• G + E = familial (aggregate) risk

• G × E = interaction term, often more significant than either G or E alone

Studies that include only G or only E will never be able to find that E is important in it interaction with G. This is why the science on determining causes has stagnated.

This model allows for:

• Non-linear amplification: low-dose exposures become high-impact in genetically susceptible individuals

• Context specificity: one exposure may be harmless in one genotype but devastating in another

• Predictive medicine: the potential for biomarker-informed interventions, tailored to an individual’s genetic and environmental profile

Over the past decade, I have called repeatedly for the immediate development and deployment of biomarker-based screening tools that can identify which children are at highest risk for vaccine injury, immune-mediated neurotoxicity, and other G × E-driven disorders​.

Kennedy’s Pledge is to Investigate G × E

Kennedy’s call for a massive, agnostic inquiry into environmental contributors to autism is deeply aligned with this framework. His announcement that HHS will examine:

• Toxic exposures (e.g., pesticides, heavy metals)

• Iatrogenic factors (e.g., vaccine adjuvants, acetaminophen)

• Mold, air and water pollution, pharmaceutical residues

… is not controversial science—it is overdue science. For decades, these factors have been epidemiologically associated with increased autism risk, but were excluded from serious research consideration under the weight of regulatory capture and reputational risk.

Now, with tools like G × E models in the forefront, researchers finally have the language, the structure, and the scientific legitimacy to pursue these questions with the rigor they require.

In the next section, we will examine specific environmental contributors with strong mechanistic and epidemiological evidence, including aluminum, thimerosal, acetaminophen, and other toxicants that—when filtered through the G × E lens—emerge not as fringe hypotheses, but as prime suspects.

Environmental Contributors to Autism: From Association to Mechanism

As gene-environment interaction (G × E) takes center stage in the autism discourse, a crucial question follows: which environmental factors merit the closest scrutiny? For decades, many of these potential contributors have been treated as speculative or dismissed outright. Yet a growing number of mechanistic and epidemiological studies—compiled extensively in my book The Environmental and Genetic Causes of Autism —show that several exposures consistently emerge as biologically plausible, causally coherent, and, most damningly, avoidable.

Unlike mere statistical correlations, the factors outlined below are backed by functional mechanisms that demonstrate how these exposures can initiate, accelerate, or exacerbate the pathophysiological processes seen in autism. When combined with genetic susceptibility or other co-exposures, these environmental insults may tip a vulnerable brain into dysfunction.

Aluminum Adjuvants in Vaccines

Aluminum salts are used as adjuvants in many pediatric vaccines to enhance immune response. But their biological persistence and neurotoxic potential are increasingly undeniable.

• Persistence and Accumulation:
  In a pivotal rabbit model study, Flarend et al. (1997) showed that only 6–22% of injected aluminum was excreted after 28 days, with the rest sequestered in tissues​. A decade-long accumulation in the brain has been observed, where aluminum persists in membrane-bound and interstitial compartments, especially in infants with immature renal function.

• Mechanism of Injury:
  Willhite et al. (2014) explained that trivalent aluminum (Al³⁺) generates superoxide radicals, which deplete mitochondrial iron, disrupt oxidative balance, and lead to intrinsic apoptosis of neural cells​. Aluminum also increases glutamate levels in the cerebrum and midbrain, promoting excitotoxicity—a key feature in autism pathophysiology​.

• G × E Amplification:
  Variants in genes governing glutamate metabolism (e.g., GRM5, GRIN2B) and mitochondrial genes (SLC25A12, MTCO1) may increase vulnerability to aluminum-induced damage.

Thimerosal (Ethylmercury)

Thimerosal, a mercury-based preservative, was removed from most pediatric vaccines in the early 2000s but persists in multi-dose influenza vaccines and in international contexts. Its mechanistic harm remains deeply relevant.

• Calcium Signaling Disruption:
  Thimerosal acts as a calcium mobilizing agent, triggering uncontrolled intracellular calcium release. Elevated Ca²⁺ in neurons can lead to oxidative stress, mitochondrial overload, and cell death​.

• Mitochondrial Vulnerability:
  Palmieri et al. (2010) found that thimerosal-exposed cells experienced mitochondrial hyperactivity and oxidative stress, even in the absence of genetic mutations—demonstrating phenomimicry​.

• Gene Susceptibility:
  MTHFR and ERAP1 variants have been linked to increased sensitivity to thimerosal-induced immunoneurotoxicity, suggesting that for some children, even low doses may pose profound risk​.

Acetaminophen After MMR and During Pregnancy

Once considered benign, acetaminophen (paracetamol) is now under intense scrutiny for its impact on neuroimmune development, particularly when administered post-vaccination or during pregnancy.

• Epidemiological Evidence:
  Early studies by Schultz et al. (2008) and Bauer et al. (2003) linked post-MMR acetaminophen use with higher rates of regression into autism​. There are now over a dozen studies that show increased risk of autism following high fever treated with acetaminophen after MMR vaccine.

• Mechanistic Links:

  • Depletes glutathione (GSH), a key antioxidant in detoxifying reactive oxygen species.

  • Alters endocannabinoid tone, which plays a role in brain development.

  • May exacerbate inflammatory reactions following immunization, especially in genetically predisposed individuals.

Maternal Immune Activation and Viral Protein Exposures

Prenatal infections and immune responses can prime fetal neuroinflammation, laying a foundation for later autistic traits.

• IL-17a Activation:
  Choi et al. (2016) demonstrated that maternal immune activation (MIA) during pregnancy triggers interleukin-17a (IL-17a) release, which leads to disorganized cortical layering in fetal brains—a hallmark of autism​.

• Historical Evidence:
  As early as Deykin and MacMahon (1979), researchers noted strong associations between autism and early-life infections like mumps, chickenpox, and fevers of unknown origin.

• Gene × Immune Synergy:
  Children with CNVs affecting immune pathways (e.g., HLA, interferon-regulatory genes) are especially vulnerable to MIA.

The literature is filled wit studies that provide evidence that maternal immune activation can be used - via infection, via vaccine adjuvant exposure - to bring on neuroinflammation and altered neurodevelopment; early-age repeated exposures to the influences also are high-priority candidates as environmental exposure factors that have been understudied.

Air Pollution, Mold, and Household Toxicants

Environmental air quality—especially in urban or industrialized areas—correlates strongly with increased autism risk.

• Traffic-related Air Pollution:
  Volatile organic compounds (VOCs) and particulate matter (PM2.5) have been linked to impaired neurogenesis and microglial priming. Children with variants in MET or CYP450 detox genes have been shown to exhibit heightened vulnerability​.

• Mycotoxins and Mold:
  Mold exposure during pregnancy or infancy can trigger chronic immune activation and neuroinflammation, especially when epigenetic methylation pathways are compromised.

Nutritional and Metabolic Factors

• Vitamin D Deficiency:
  Low maternal vitamin D levels have been associated with increased ASD risk, due to its role in regulating immune tolerance and reducing neuroinflammation​.

• Protein Malnutrition:
  Malnutrition can amplify the neurotoxic effects of aluminum and mercury by impairing detoxification systems and energy metabolism.

---

Why These Exposures Matter Now

The central insight from the science amplified by Kennedy—is that these exposures do not act in isolation. They are layered, interactive, and potentially synergistic, particularly in genetically susceptible children.

Yet the public health establishment has failed to act on this evidence, favoring vague polygenic models and "more awareness" narratives over mechanistic toxicology and real prevention. For example:

• The CDC’s own autism prevalence reports do not contain the words “toxic,” “vaccine,” or “environment”—a telling silence​.

• No federal agency has funded a systematic study of biomarkers of susceptibility, such as maternal anti-brain antibodies, aluminum sensitivity or mitochondrial profiling, to stratify risk.

Kennedy’s directive to explore these environmental variables using modern tools—including real-time surveillance and AI-powered causal inference—represents a fundamental shift. It signals not only a scientific awakening, but a moral one: we must stop protecting the narratives of captured agencies and start protecting children.

In the next section, we will directly confront the counterarguments made by denialist voices in the mainstream—particularly those echoed in NPR’s coverage—and respond with the empirical clarity that this crisis demands.

Responding to Denialism: Rebuttals to Mainstream Counterarguments

As Robert F. Kennedy Jr. and leading autism researchers sounded the alarm about rising autism prevalence, mainstream outlets like NPR responded not with curiosity or concern—but with a predictable pattern of dismissal, deflection, and rhetorical containment. The April 16, 2025 All Things Considered segment offered a case study in this institutional reflex, parroting long-debunked tropes while ignoring the very data their own sources helped produce​.

Below, we engage with the core counterarguments and offer direct, evidence-based rebuttals drawn from the CDC’s own data, peer-reviewed literature, and in my book, published ten years ago.

---

Denialist Claim 1: “The increase is due to better screening and awareness.”

🧠 Rebuttal:

This is factually indefensible.

• CDC data show that nearly two-thirds of children diagnosed with autism in 2022 had IQs below 85, a trend that has increased, not decreased, over time​​. These are not children being diagnosed because we’re "noticing quirks"—they are profoundly affected.

• If improved detection were the cause, we would expect a rise in high-functioning, borderline cases. The opposite is happening.

• Longitudinal studies, like the 1987 North Dakota cohort followed for 12 years, showed that under older diagnostic criteria, researchers missed only one autism case among over 180,000 children. To accept NPR’s premise, we’d have to believe they missed 98.8% of cases, which is implausible and statistically absurd​​.

---

Denialist Claim 2: “Autism is caused by hundreds or thousands of genetic factors, not environmental ones.”

🧬 Rebuttal:

This is a scientific mischaracterization.

• No gene accounts for more than 1% of ASD risk. Even the most comprehensive GWAS studies explain only a tiny fraction of heritability and fail to predict phenotype reliably​.

• Sandin et al. (2014) and Hallmayer et al. (2011) both show that at least 50% of autism liability is environmental or due to gene-environment interaction​.

• Many cited genes are phenotypically non-specific, associated equally with schizophrenia, ADHD, and intellectual disability. Without environmental context, these “associations” are epidemiological artifacts.

• Worse, this framing hides the fact that many environmental exposures mimic genetic mutations, via epigenetic modifications or receptor pathway disruption—a process known as phenomimicry​.

---

Denialist Claim 3: “Vaccines don’t cause autism—it’s been debunked.”

💉 Rebuttal:

This is disingenuous and based on flawed science.

• Many studies used to claim vaccines are “safe”:

  • Compare vaccinated to recently vaccinated children.

  • Omit susceptible subgroups (e.g., those with SCN1A or MTHFR polymorphisms).

  • Exclude regressive autism cases after post-vaccine febrile seizures or encephalopathy.

  • Fail to investigate G × E interactions, despite extensive biological evidence for them.

• A key IPAK research study exposed how the Mitkus model, used by the FDA to declare aluminum adjuvants safe, makes unrealistic assumptions, undervalues accumulation in brain tissue, ignores immature renal function in infants, and assumes rapid clearance that doe not reflect reality​.

• CDC;s historic “studies” claiming “no link” are generally underpowered, statistically manipulated, or designed not to find a signal.

• As Kennedy said: “We’re going to look at all the causes, not just the ones the pharmaceutical industry finds comfortable.”

---

Denialist Claim 4: “It’s harmful to say autism is an epidemic—it stigmatizes the autistic community.”

⚖️ Rebuttal:

This is a false binary and a manipulative emotional appeal.

• No one disputes the value and dignity of autistic individuals. But acknowledging the disabling nature of profound autism—where children are non-verbal, self-injurious, or require 24/7 care—is not stigma; it is honesty.

• As Kennedy clarified: “These are children who regressed. They didn’t choose this. Their suffering—and their families’ suffering—is real.”

• The romanticization of neurodivergence has been used to protect industry and forestall hard questions, not to help families of severely affected individuals​.

• The real stigma lies in gaslighting families, denying their observations, and offering no explanation other than “your genes did this.”

---

Denialist Claim 5: “We should focus on helping autistic people now, not chasing causes.”

🩺 Rebuttal:

This is a false dichotomy.

• We can—and must—do both. Understanding causation is itself an act of compassion, enabling targeted prevention, individualized care, and reduction of suffering for future generations​.

• Kennedy's HHS has not proposed cutting services—he is proposing a parallel track: fund support and fund real causality research.

• Every chronic condition we now manage well—diabetes, asthma, epilepsy—was once mysterious until someone asked why. Autism should be no different.

---

Denialist Claim 6: “The Trump administration is just using autism to promote an anti-vaccine agenda.”

🧭 Rebuttal:

This is political noise, not a scientific argument.

• Autism is not partisan. The data speak for themselves—and they’ve been ignored by both Republican and Democratic administrations for decades.

• Kennedy’s initiative is not about ideology—it’s about correcting a catastrophic failure in scientific inquiry, restoring transparency, and liberating researchers to follow the data wherever it leads.

• Scientists like and others have sounded the alarm for years, only to be sidelined by politically safe narratives and captured agencies.

• The goal is not “vindication.” It’s prevention.

---

In sum, the denialist framework is no longer tenable—not scientifically, not morally, and not politically. As Kennedy said at the close of his press conference:

“Genes do not cause epidemics. We are going to find out what does. And we are going to stop it.”

In the next section, we will examine how Kennedy’s proposed realignment of HHS research priorities aims to operationalize that goal—by funding the kind of rigorous, agnostic science that institutions have long suppressed.

Rebuilding Public Health Science: Kennedy’s Strategic Realignment of HHS Research Priorities

With a decades-long record of advocacy on environmental health and vaccine safety, Robert F. Kennedy Jr.’s appointment to lead the Department of Health and Human Services (HHS) marked a sea change—not just in personnel, but in purpose. His April 2025 press conference made clear that this administration is not merely reforming the research agenda. It is rewiring the logic of public health inquiry.

At the center of this realignment is a three-part strategic pivot:

1. Agnostic causality research—no preemptive exclusions;

2. Reprioritization of funding streams, with emphasis on environmental, toxicological, and G × E research;

3. Technological modernization, enabling real-time data surveillance and AI-enhanced causal inference.

Together, these reforms signal a decisive move away from the narrative-driven science of prior administrations and toward evidence-led inquiry that welcomes complexity, uncertainty, and inconvenient findings.

---

An Agnostic, Open-Ended Research Mandate

Kennedy's clearest departure from past leadership lies in his refusal to shield any hypothesis from scrutiny.

• “We are going to look at all plausible causes of autism,” he declared. “Not just the politically safe ones.”
  This includes:

  • Vaccine adjuvants (e.g., aluminum)

  • Postnatal acetaminophen exposure

  • Prenatal environmental toxins

  • Food additives and endocrine disruptors

  • Air and water pollution

  • Mold exposure and household chemicals

  • Ultra-processed food and dysbiosis

• For the first time in agency history, HHS has pledged to investigate vaccine injury mechanisms without censorship—a move warmly welcomed and long overdue by parents and objective scientists and doctors who have long argued that the suppression of such inquiry has left millions of questions unanswered and families unsupported​.

• Kennedy emphasized the need for real-time analysis of adverse event signals, and committed to building the infrastructure to support open-source, continuous-data research on ASD causality.

---

Rebalancing Research Funding: Genetics vs. Environment

Historically, the NIH and HHS have allocated the vast majority of autism research funding—as much as 95% in some years—to genetics, behavioral training, and services. Environmental causation has been treated as a fringe concern, relegated to small, unfunded subfields or shut down entirely when it veered into politically sensitive territory.

• Kennedy pledged to correct this imbalance, calling the genetics-heavy approach a “dead end.”
  “We’ve spent billions studying genes and gotten nowhere in terms of prevention,” he said.

• Most “autism genes” lack predictive utility, and that many implicated pathways (e.g., glutamate, mitochondrial function, serotonin regulation) are environmentally modifiable​.

• Under Kennedy’s plan, environmental causality studies will receive priority status. This includes funding for:

  • Independent toxicological studies;

  • Large-scale retrospective cohort studies with environmental exposure data;

  • Real-world population studies stratified by known susceptibility biomarkers.

---

Embracing Technological Innovation: Real-Time Surveillance and AI Modeling

Public health research has long lagged behind modern data science. Kennedy aims to change that.

• The CDC currently publishes autism prevalence data with a two-year delay—an absurd latency in the era of cloud computing and real-time epidemiological dashboards.

• Kennedy has ordered the CDC and affiliated agencies to build real-time monitoring systems capable of detecting shifts in prevalence, exposure correlation, and geographic clustering as they happen, not years later.

• AI-assisted tools, including machine learning algorithms trained on G × E data, will be employed to:

  • Detect non-linear risk patterns;

  • Flag synergistic toxicant interactions;

  • Identify overlooked subgroups (e.g., children with low detox capacity, specific CNVs, or immune dysregulation markers);

  • Test new hypotheses generated by unsupervised data mining.

• Once again, we should call for phased biomarker-informed predictive modeling, which could eventually be used to guide early interventions or exemption decisions for at-risk children​.

---

Finally: Freedom to Follow the Data

One of Kennedy’s most forceful points at the press conference was his commitment to scientific freedom:

“Researchers will know that they can follow the science, wherever it leads, without fear of censorship, gaslighting, professional retaliation, or loss of funding.”

This is no small promise. Scientists like Brian Hooker, Walter Zahorodny, Cynthia Nevison, and myself have long faced marginalization for publishing results that challenge the institutional status quo.

Kennedy’s HHS is creating a framework in which data, not dogma, will determine scientific direction. This includes:

• Encouraging independent grant applicants outside the NIH echo chamber;

• Protecting whistleblowers and dissenting researchers from retaliation;

• Funding replication studies of previously suppressed or dismissed findings;

• Creating pre-registration incentives and transparent publication pipelines to prevent publication bias and data manipulation.

---

Rebuilding Trust in Science by Restoring Integrity

Public trust in public health has eroded—not because of “misinformation,” but because institutions repeatedly chose public messaging over public accountability. Kennedy’s model flips that equation.

• By welcoming uncomfortable questions, restoring open debate, and funding dispassionate, hypothesis-neutral research, HHS can become a source of clarity, not confusion.

• The credibility crisis in autism science will not end until the funding system is rebuilt on independence, reproducibility, and honesty. Kennedy’s initiative is the first major effort to do just that.

---

In the next section, we will explore the economic and ethical imperatives of this research realignment—examining the staggering financial toll of the autism epidemic, and why inaction is no longer merely negligent, but indefensible.

The Cost of Inaction: Economic, Moral, and Scientific Failure

If the soaring autism rates were merely a statistical artifact—as some officials still insist—they would have no real cost beyond better recordkeeping. But that narrative collapses under the weight of not only empirical data, but also economic projections, caregiving realities, and the systemic breakdowns playing out in communities across the country. The price of inaction is not theoretical—it is unfolding in real time, in billions of dollars, broken families, and squandered futures.

Economic Impact: A Trillion-Dollar Catastrophe

The financial toll of the autism epidemic is staggering.

• A 2020 projection by Buescher et al. estimated that by 2060, the annual cost of autism care in the U.S. could exceed $5.54 trillion if current prevalence trends continue​​.

• This figure includes:

  • Direct medical costs (diagnosis, therapies, hospitalizations);

  • Special education services;

  • Long-term care and group housing;

  • Lost productivity for autistic individuals and their caregivers.

• Already, autism-related spending exceeds the budgets of multiple federal agencies combined, yet nearly all funds are channeled toward support services, not prevention.

• Crucially, as Kennedy noted, many of the children being diagnosed today will never enter the workforce, pay taxes, or live independently. This has profound implications for national productivity, public health burden, and the future solvency of disability systems.

“We are not just losing individuals,” Kennedy stated. “We are losing generations of human potential.”

The Moral Cost: Neglect Disguised as Inclusion

While the economic burden is measurable, the moral cost is harder to quantify—and even harder to justify.

• Millions of families across the U.S. are now navigating life with a child who may never speak, never learn to use the toilet, never form relationships, and never achieve independence.

• Contrary to narratives that promote autism as a “difference,” many parents—especially those raising non-verbal, seizure-prone, or self-injurious children—describe the experience as one of isolation, fear, and endless advocacy for services that are chronically underfunded and often unavailable.

• Calling these outcomes “neurodiversity” may bring comfort to some, but for many others, it masks the preventable harm that has befallen their children. He writes:

“To refuse to study causation is to condemn the next generation to the same fate. It is to enshrine suffering as acceptable, and to rob parents of the chance to protect their children”​.

• The mainstream reflex to label any focus on causation as “stigmatizing” is a dangerous inversion of logic. It is not stigmatizing to seek answers. It is stigmatizing to tell devastated families that their pain must be celebrated as diversity, while refusing to even ask why it happened.

Scientific Reputational Collapse: A System That Protected Itself

The institutional failure to pursue environmental causation—especially when supported by plausible mechanisms and rising epidemiology—has compromised the legitimacy of entire agencies.

• The CDC’s own reports omit the terms “toxic,” “vaccine,” “pollution,” or “environment”, despite a 300% rise in ASD prevalence in 20 years​.

• The NIH’s lopsided funding (20:1 in favor of genetic vs. environmental studies) persists despite:

  • Environmental causation explaining at least 50% of autism liability;

  • No genetic variant accounting for more than 1% of cases;

  • Decades of failed gene-targeted interventions​.

• We know that methodological sabotage (e.g., selective cohort design, underpowered vaccine safety studies, statistical manipulation) has become normalized in autism research, eroding public trust in science itself​.

“If we cannot speak the truth about autism,” he writes, “we can no longer speak the truth about anything.”

• This crisis of credibility extends beyond academia. Public health messaging has become so captured by the need to preserve confidence in existing programs that it has abandoned scientific humility and accountability. Kennedy’s call to rebuild science from first principles is not reactionary—it is remedial.

---

The Opportunity Cost: Lost Time, Lost Lives

The greatest cost of all is the one least discussed: what could have been prevented had the right questions been asked decades ago.

• If the CDC had tracked aluminum accumulation in the brain post-vaccination;

• If the NIH had funded G × E toxicology research in the 1990s;

• If pediatricians were trained to recognize environmental susceptibility biomarkers;

• If the FDA had not relied on the flawed Mitkus model to defend aluminum safety;

…then perhaps the epidemic Kennedy decried would not have reached 1 in 12.5 boys in California by 2025.

Instead, those who raised red flags—scientists, clinicians, and especially parents—were ignored, smeared, or de-platformed. This is not a harmless oversight. It is a collective failure of epistemic stewardship—the duty to follow the truth wherever it leads, not merely where it is comfortable.

---

In the final section, we will articulate why this moment must be remembered not merely as a policy turning point, but as the dawn of a new scientific ethos—one rooted in humility, responsibility, and a renewed commitment to the children we failed to protect.

A Turning Point for Science, Public Health, and the Next Generation

There are moments in scientific and political history when the prevailing narrative collapses under the weight of data, experience, and moral clarity. These are inflection points—not because the facts are new, but because the cost of ignoring them has become unbearable. April 16, 2025 may be remembered as one such moment.

In the stark light of government-validated data, rising parental testimony, and a deepening ecological crisis in children’s health, Secretary Robert F. Kennedy Jr. stood before the American people and declared what millions already knew but few in power dared to say: autism is an epidemic, and we have failed to confront its causes. With that simple admission, Kennedy cracked open a vault of long-suppressed questions—and invited science, for the first time in decades, to walk inside without fear.

His message was not ideological. It was empirical. It was not stigmatizing. It was compassionate. And it was not speculative. It was grounded in work meticulously assembled in The Environmental and Genetioc Causes of Autism the evidence base that institutional science refused to acknowledge—mapping gene-environment interactions, dismantling flawed heritability claims, exposing methodological sabotage in vaccine safety research, and demanding a return to first-principles science guided by biological plausibility and epidemiological integrity.

This convergence of scientific courage and political leadership has created an opening—not only for autism research, but for the reconstruction of public health science as a trustworthy, unconflicted discipline. That reconstruction must be built on several foundations:

Scientific Agnosticism, Not Dogma

Public health must no longer preordain the outcome of investigations. Whether studying vaccine safety, air pollution, food additives, or prenatal pharmaceuticals, researchers must be free to follow the evidence without concern for reputational risk or political backlash.

Methodological Rigor, Not Messaging

Public trust depends on methods that can be replicated, interrogated, and falsified. Kennedy’s call for AI-assisted, real-time, open-source epidemiology reflects a recognition that science without transparency is no longer science—it is PR.

Accountability, Not Appeasement

Agencies like the CDC, NIH, and FDA must recognize their past failures—in funding, in surveillance, in disclosure—and make institutional amends by reorienting their mission toward protecting the public, not protecting narratives.

Empathy Rooted in Truth, Not Euphemism

To romanticize suffering is not advocacy. To ignore it is not inclusion. As the autism prevalence climbs and the severity profile shifts toward profound disability, families are crying out not for platitudes, but for protection, answers, and preventive action.

---

The Stakes Are Generational

This is not merely a fight for better research. It is a fight for the human potential of our children. It is a reckoning with the idea that our environment—chemical, medical, industrial—has changed faster than our regulatory systems were ever designed to handle. It is a call to stop sacrificing biological integrity at the altar of institutional convenience.

If Kennedy’s initiative succeeds, it will not only reshape autism science—it will set a precedent for how complex, multifactorial conditions should be studied in the 21st century. G × E models. Biomarker-informed risk stratification. Real-time data surveillance. And above all, humility before the complexity of life.

Truth has a shape. If we are willing to turn toward it—together, with courage—we may yet heal not only our children, but the broken logic that led us here.

That healing begins now. And this time, it begins with science unshackled.

• Buescher, A. V. S., Cidav, Z., Knapp, M., & Mandell, D. S. (2014). Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatrics, 168(8), 721–728. https://doi.org/10.1001/jamapediatrics.2014.210​

• Choi, G. B., Yim, Y. S., Wong, H., Kim, S., Kim, H., Kim, S. V., ... & Huh, J. R. (2016). The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring. Science, 351(6276), 933–939. https://doi.org/10.1126/science.aad0314​

• Deykin, E. Y., & MacMahon, B. (1979). Viral exposure and autism. American Journal of Epidemiology, 109(6), 628–638. https://doi.org/10.1093/oxfordjournals.aje.a112729

• Flarend, R., Hem, S. L., White, J. L., Elmore, D., Suckow, M., Rudy, A. C., & Dandashli, A. (1997). In vivo absorption of aluminium-containing vaccine adjuvants using 26Al. Vaccine, 15(12–13), 1314–1318. https://doi.org/10.1016/S0264-410X(97)00041-8​

• Hallmayer, J., Cleveland, S., Torres, A., Phillips, J., Cohen, B., Torigoe, T., ... & Risch, N. (2011). Genetic heritability and shared environmental factors among twin pairs with autism. Archives of General Psychiatry, 68(11), 1095–1102. https://doi.org/10.1001/archgenpsychiatry.2011.76​

• Lyons-Weiler, J. (2016). The Environmental and Genetic Causes of Autism. Skyhorse Publishing. ISBN: 9781510710863​

• Mazina, V., Gerdts, J., Trinh, S., Ankenman, K., Ward, T., Dennis, M. Y., & Bernier, R. (2015). Epigenetics and gene-environment interactions in autism spectrum disorders: Empirical evidence and methodological considerations. Neuroscience & Biobehavioral Reviews, 55, 243–252. https://journals.lww.com/jrnldbp/abstract/2015/02000/epigenetics_of_autism_related_impairment__copy.3.aspx​

• Mitkus, R. J., King, D. B., Hess, M. A., Forshee, R. A., & Walderhaug, M. O. (2011). Updated aluminum pharmacokinetics following infant exposures through diet and vaccination. Vaccine, 29(51), 9538–9543. https://doi.org/10.1016/j.vaccine.2011.09.124​

• Nevison, C. D. (2014). A comparison of temporal trends in United States autism prevalence to trends in suspected environmental factors. Environmental Health, 13(1), 73. https://doi.org/10.1186/1476-069X-13-73​

• Palmieri, L., Papaleo, V., Porcelli, V., Scarcia, P., Gaita, L., Sacco, R., ... & Persico, A. M. (2010). Altered calcium homeostasis in autism-spectrum disorders: Evidence from studies on Thimerosal and mitochondria. Translational Psychiatry, 1, e11. https://doi.org/10.1038/tp.2011.11​

• Sandin, S., Lichtenstein, P., Kuja-Halkola, R., Larsson, H., Hultman, C. M., & Reichenberg, A. (2014). The familial risk of autism. JAMA, 311(17), 1770–1777. https://doi.org/10.1001/jama.2014.4144​

• Schultz, S. T., Klonoff-Cohen, H. S., Wingard, D. L., Akshoomoff, N. A., Macera, C. A., Ji, M., & Bacher, C. (2008). Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder: The results of a parent survey. Autism, 12(3), 293–307. https://doi.org/10.1177/1362361307089518 ​

• Willhite, C. C., Karyakina, N. A., Yokel, R. A., Yenugadhati, N., Wisniewski, T. M., Bielmeier, S. R., ... & Rogers, J. M. (2014). Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its salts. Critical Reviews in Toxicology, 44(Suppl 4), 1–80. https://doi.org/10.3109/10408444.2014.934439​

• Zahorodny, W., Shenouda, J., Sidwell, K., Verile, M., Alvarez, C., Fusco, A., Mars, A., Waale, M., Gleeson, T., Burack, G., & Zumoff, P. (2023). Prevalence and characteristics of adolescents with autism spectrum disorder in the New York–New Jersey metropolitan area. Journal of Autism and Developmental Disorders. Advance online publication. https://doi.org/10.1007/s10803-023-06058-8​

• Centers for Disease Control and Prevention (CDC). (2025). Autism and Developmental Disabilities Monitoring Network Report. https://www.cdc.gov/autism/addm-network/index.html

• Stein, R., & Wroth, C. (2025, April 16). RFK pushes to find ‘environmental’ cause of autism, calls growing rates an ‘epidemic’. NPR – All Things Considered. https://www.mynspr.org/2025-04-16/rfk-pushes-to-find-environmental-cause-of-autism-calls-growing-rates-an-epidemic

Dr. Lyons-Weiler is the CEO of IPAK, Founder of IPAK-EDU.org, Editor-in-Chief of the open-access research journal Science, Public Health Policy & the Law, and author of Popular Rationalism free to all Substack.